Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
Authors
Keywords
Hyperkalemia, RASi, Target-trial emulation, Death, MACE
Journal
AMERICAN HEART JOURNAL
Volume 243, Issue -, Pages 177-186
Publisher
Elsevier BV
Online
2021-10-04
DOI
10.1016/j.ahj.2021.09.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care
- (2021) Marco Trevisan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Patterns of chronic and transient hyperkalemia and clinically-important outcomes in patients with chronic kidney disease
- (2021) Marco Trevisan et al. Clinical Kidney Journal
- Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
- (2020) Patrick Rossignol et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
- (2020) Yao Qiao et al. JAMA Internal Medicine
- Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
- (2020) Patrick Bidulka et al. BMC Medicine
- Hyperkalaemia and hypokalaemia outpatient management: a survey of 500 French general practitioners
- (2020) Laure Abensur Vuillaume et al. ESC Heart Failure
- Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study
- (2020) Edouard L. Fu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
- (2020) Edouard L Fu et al. Clinical Kidney Journal
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Rajiv Agarwal et al. LANCET
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Catherine M. Clase et al. KIDNEY INTERNATIONAL
- Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
- (2019) Yao Qiao et al. MAYO CLINIC PROCEEDINGS
- Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
- (2019) Cecilia Linde et al. Journal of the American Heart Association
- Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality
- (2019) Joost C. Beusekamp et al. JACC-Heart Failure
- Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
- (2018) Marco Trevisan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Merits and caveats of propensity scores to adjust for confounding
- (2018) Edouard L Fu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Clinical and research implications of serum versus plasma potassium measurements
- (2018) Lauren B. Cooper et al. EUROPEAN JOURNAL OF HEART FAILURE
- Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
- (2017) Erik Nilsson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2017) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
- (2017) Morten Schmidt et al. BMJ Open
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
- (2016) Miguel A. Hernán et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
- (2016) Miguel A. Hernán et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
- (2015) Matthew R. Weir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium Zirconium Cyclosilicate in Hyperkalemia
- (2015) David K. Packham et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data
- (2010) Lauren E. Cain et al.
- HFSA 2010 Comprehensive Heart Failure Practice Guideline
- (2010) Heart Failure Society of America JOURNAL OF CARDIAC FAILURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now